CUNY TV logo

 

This edition: Testing New Drugs: Are People Guinea Pigs?





Online media for this show is not available on our website.

Episode Details

Instituted in the sixties, clinical drug trials today have become a vast and expensive enterprise in which drug companies can spend over $100 million to bring a new molecule to market. FDA procedures are complex and elaborate as they should be, in order to bring new drugs to market quickly to help people in need, but to do good science to protect the public from a drug's potentially dangerous side effects.